Update zu PSSM und MFM – Fokus auf das Warmblut

In den letzten Jahren hat die Forschung zu PSSM und MFM große Fortschritte gemacht. In diesem Artikel werden die verschiedenen belastungsassoziierten Myopathien sowie die neuen, detaillierteren Empfehlungen im Bereich Diagnostik und Therapie mit besonderem Fokus auf Warmblutpferde dargestellt.

Publikationsverlauf

Artikel online veröffentlicht:
17. Juni 2025

• Literatur

• 1 GPM – Gesellschaft für Pferdemedizin. PSSM – unspezifische Symptomatik und mangelnde Aussagekraft von Gentests. Pferdespiegel 2023; 26: 50-51
• 2 Valberg SJ, Williams ZJ. Myofibrillar Myopathy. Vet Clin North Am Equine Pract 2025; 41: 139-150
• 3 Pagan JD, Valberg SJ. The Role of Nutrition in Managing Muscle Disorders. Vet Clin North Am Equine Pract 2025; 41: 151-163
• 4 Valberg SJ, Cardinet GH, Carlson GP. et al. Polysaccharide storage myopathy associated with recurrent exertional rhabdomyolysis in horses. Neuromuscul Disord 1992; 2: 351-359
• 5 Valentine BA, Cooper BJ. Incidence of polysaccharide storage myopathy: necropsy study of 225 horses. Vet Pathol 2005; 42: 823-827
• 6 McCue ME, Ribeiro WP, Valberg SJ. Prevalence of polysaccharide storage myopathy in horses with neuromuscular disorders. Equine Vet J Suppl 2006; 38: 340-344
• 7 McCue ME, Valberg SJ, Miller MB. et al. Glycogen synthase (GYS1) mutation causes a novel skeletal muscle glycogenosis. Genomics 2008; 91: 458-466
• 8 Firshman AM, Baird JD, Valberg SJ. Prevalences and clinical signs of polysaccharide storage myopathy and shivers in Belgian Draft Horses. J Am Vet Med Assoc 2005; 227: 1958-1964
• 9 Ayad A, Besseboua O, Aissanou S. et al. Profiling of genetic markers useful for breeding decision in Selle Francais horse. J Equine Vet Sci 2022; 116: 104059
• 10 Lewis SS, Nicholson AM, Williams ZJ. et al. Clinical characteristics and muscle glycogen concentrations in warmblood horses with polysaccharide storage myopathy. American J Vet Res 2017; 78: 1305-1312
• 11 McKenzie EC, Eyrich LV, Payton ME. et al. Clinical, histopathological and metabolic responses following exercise in Arabian horses with a history of exertional rhabdomyolysis. Vet J 2016; 216: 196-201
• 12 Valberg SJ, McKenzie EC, Eyrich LV. et al. Suspected myofibrillar myopathy in Arabian horses with a history of exertional rhabdomyolysis. Equine Vet J 2016; 48: 548-556
• 13 Williams ZJ, Bertels M, Valberg SJ. Muscle glycogen concentrations and response to diet and exercise regimes in Warmblood horses with type 2 Polysaccharide Storage Myopathy. PLoS ONE 2018; 13: e0203467
• 14 Shell K. Muskelerkrankungen beim Pferd. Online Seminar 25.06.2024
• 15 Valberg SJ, Perumbakkam S, McKenzie EC. et al. Proteome and transcriptome profiling of equine myofibrillar myopathy identifies diminished peroxiredoxin 6 and altered cysteine metabolic pathways. Physiol Genomics 2018; 50: 1036-1050
• 16 Valberg SJ, Nicholson AM, Lewis SS. et al. Clinical and histopathological features of myofibrillar myopathy in Warmblood horses. Equine Vet J 2017; 49: 739-745
• 17 Walters JM, Parkin T, Snart HA. et al. Current management and training practices for UK dressage horses. Comp Exerc Physiol 2008; 5: 73-83
• 18 Valberg SJ. Diagnosis and Management of Myofibrillar Myopathy in Warmblood Performance Horses. Proceedings of the 67th Annual Convention of the American Association of Equine Practitioners 2021; 67: 214-218
• 19 Valberg SJ, Finno CJ, Henry ML. et al. Commercial genetic testing for type 2 polysaccharide storage myopathy and myofibrillar myopathy does not correspond to a histopathological diagnosis. Equine Vet J 2021; 53: 690-700
• 20 Valberg SJ, Williams ZJ, Finno CJ. et al. Type 2 polysaccharide storage myopathy in Quarter Horses is a novel glycogen storage disease causing exertional rhabdomyolysis. Equine Vet J 2023; 55: 618-631
• 21 Valberg SJ, Henry ML, Herrick KL. et al. Absence of myofibrillar myopathy in Quarter Horses with a histopathological diagnosis of type 2 polysaccharide storage myopathy and lack of association with commercial genetic tests. Equine Vet J 2023; 55: 230-238
• 22 Ribeiro WP, Valberg SJ, Pagan JD. et al. The effect of varying dietary starch and fat content on serum creatine kinase activity and substrate availability in equine polysaccharide storage myopathy. J Vet Intern Med 2004; 18: 887-894
• 23 Annandale EJ, Valberg SJ, Mickelson JR. et al. Insulin sensitivity and skeletal muscle glucose transport in horses with equine polysaccharide storage myopathy. Neuromuscul Disord 2004; 14: 666-674
• 24 Valberg SJ, MacLeay JM, Mickelson JR. Exertional rhabdomyolysis and polysaccharide storage myopathy in horses. Comp Cont Educ Vet 1997; 19: 1077-1085
• 25 Valentine BA, Hintz HF, Freels KM. et al. Dietary control of exertional rhabdomyolysis in horses. J Am Vet Med Assoc 1998; 212: 1588-1593
• 26 Valentine BA, Van Saun RJ, Thompson KN. et al. Role of dietary carbohydrate and fat in horses with equine polysaccharide storage myopathy. J Am Vet Med Assoc 2001; 219: 1537-1544
• 27 Graham-Thiers PM, Kronfeld DS. Amino acid supplementation improves muscle mass in aged and young horses. J Anim Sci 2005; 83: 2783-2788
• 28 Valberg SJ, McCue ME, Mickelson JR. The interplay of genetics, exercise, and nutrition in polysaccharide storage myopathy. J Equine Vet Sci 2011; 31: 205-210
• 29 Prince A, Geor R, Harris P. et al. Comparison of the metabolic responses of trained Arabians and Thoroughbreds during high- and low-intensity exercise. Equine Vet J Suppl 2002; 34: 95-99